A WORLD THAT EVOLVES… EACH DAY

Manufacturer

Nystatin production initiated in Antibiotice in 1997, when the biosynthesis activity was adjusted to the requirements of the international market. The need to permanently adapt to our partners’ requirements as well as the constant concern for the improvement of product quality determined significant investments in the production lines. These investments resulted in the obtaining of the Good Manufacturing Practice certificate and Food and Drug Administration acceptance, which allowed the active ingredient enter the US and Canadian markets. The Certificate of Suitability RO-CEP 2003-096-Rev 00 issued by EDQM in May 2005 confirmed once again the superior quality of Nystatin. At present, Antibiotice is the second world producer of Nystatin, with a market share of 25%

List of Products

Back